ISSN 2306-5559 (print)
ISSN 2410-938X (online)
ISSN 2410-938X (online)
The authors declare no potentialconfict of interest requiring disclosurein this article.
Head of the Radiology Department
1. SuYY, ChiangNJ, ChiuTJ, HuangCJ, HsuSJ, LinHC, YangSH, YangY, ChouWC, ChenYY, BaiLY, LiCP, ChenJS. Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. Biomed J. 2024 Jun;47(3):100696. doi: 10.1016/j.bj.2023.100696. 2. Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, Gao F. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021 Jul 21;27(27):4298-4321. doi: 10.3748/wjg.v27.i27.4298. 3. Kenner B, Chari ST, Kelsen D, Klimstra DS, Pandol SJ, Rosenthal M, Rustgi AK, Taylor JA, Yala A, Abul-Husn N, Andersen DK, Bernstein D, Brunak S, Canto MI, Eldar YC, Fishman EK, Fleshman J, Go VLW, Holt JM, Field B, Goldberg A, Hoos W, Iacobuzio-Donahue C, Li D, Lidgard G, Maitra A, Matrisian LM, Poblete S, Rothschild L, Sander C, Schwartz LH, Shalit U, Srivastava S, Wolpin B. Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review.Pancreas. 2021 Mar 1;50(3):251-279. doi: 10.1097/MPA.0000000000001762. 4. Rhee H, Park MS. The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma. Korean J Radiol. 2021 Jan;22(1):23-40. doi: 10.3348/kjr.2019.0862. 5. Latenstein AEJ, van der Geest LGM, Bonsing BA, et al. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur J Cancer. 2020;125:83-93. 6. Kirkegard J, Bojesen AB, Nielsen MF, et al. Trends in pancreatic cancer incidence, characteristics, and outcomes in Denmark 1980-2019: a nationwide cohort study. Cancer Epidemiol. 2022;80:102230.7. Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, Gao F. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021 Jul 21;27(27):4298-4321. doi: 10.3748/wjg.v27.i27.4298. 8. Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O'Reilly EM, Hackert T, Golan T, Prager G, Haustermans K, Vogel A, Ducreux M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023 Nov;34(11):987-1002. doi: 10.1016/j.annonc.2023.08.009.9. TemperoMA, MalafaMP, Al-HawaryM, BehrmanSW, BensonAB, CardinDB, ChioreanEG, ChungV, CzitoB, DelChiaroM, DillhoffM, DonahueTR, DotanE, FerroneCR, FountzilasC, HardacreJ, HawkinsWG, KluteK, KoAH, KunstmanJW, LoConteN, LowyAM, MoravekC, NakakuraEK, NarangAK, ObandoJ, PolancoPM, ReddyS, ReyngoldM, ScaifeC, ShenJ, VollmerC, WolffRA, WolpinBM, LynnB, GeorgeGV.Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J NatlComprCancNetw. 2021 Apr 1;19(4):439-457. doi: 10.6004/jnccn.2021.0017.10. Yang H, Li W, Ren L, Yang Y, Zhang Y, Ge B, Li S, Zheng X, Liu J, Zhang S, DU G, Tang BO, Wang H, Wang J. Progress on diagnostic and prognostic markers of pancreatic cancer. OncolRes. 2023 Apr 10;31(2):83-99. doi: 10.32604/or.2023.028905. 11. Olakowski M, Grudzińska E. Pancreatic head cancer - Current surgery techniques. Asian J Surg. 2023 Jan;46(1):73-81. doi: 10.1016/j.asjsur.2022.05.117. 12. Chen X, Liu F, Xue Q, Weng X, Xu F. Metastatic pancreatic cancer: Mechanisms and detection (Review). Oncol Rep. 2021 Nov;46(5):231. doi: 10.3892/or.2021.8182. 13. Liu W, Zhang B, Liu T, Jiang J, Liu Y. Artificial Intelligence in Pancreatic Image Analysis: A Review. Sensors (Basel). 2024 Jul 22;24(14):4749. doi: 10.3390/s24144749.